260 related articles for article (PubMed ID: 8434649)
1. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
[TBL] [Abstract][Full Text] [Related]
2. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
3. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
[TBL] [Abstract][Full Text] [Related]
4. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
[TBL] [Abstract][Full Text] [Related]
5. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.
Peoples GE; Anderson BW; Lee TV; Murray JL; Kudelka AP; Wharton JT; Ioannides CG
Clin Cancer Res; 1999 Dec; 5(12):4214-23. PubMed ID: 10632363
[TBL] [Abstract][Full Text] [Related]
6. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
7. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
8. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies.
Rettig WJ; Cordon-Cardo C; Koulos JP; Lewis JL; Oettgen HF; Old LJ
Int J Cancer; 1985 Apr; 35(4):469-75. PubMed ID: 2580800
[TBL] [Abstract][Full Text] [Related]
9. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
12. Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
Zhang S; Zhang HS; Cordon-Cardo C; Ragupathi G; Livingston PO
Clin Cancer Res; 1998 Nov; 4(11):2669-76. PubMed ID: 9829729
[TBL] [Abstract][Full Text] [Related]
13. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
14. Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.
van Niekerk CC; Vooijs P; Casparie-van Velsen IJ; Poels LG
Cancer Detect Prev; 1997; 21(3):247-57. PubMed ID: 9167042
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F
Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701
[TBL] [Abstract][Full Text] [Related]
16. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences.
Ciriş M; Erhan Y; Zekioglu O; Bayramoglu H
Acta Obstet Gynecol Scand; 2004 May; 83(5):491-6. PubMed ID: 15059165
[TBL] [Abstract][Full Text] [Related]
17. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
[TBL] [Abstract][Full Text] [Related]
18. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y
Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
